1. Home
  2. GNPX vs CVR Comparison

GNPX vs CVR Comparison

Compare GNPX & CVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GNPX
  • CVR
  • Stock Information
  • Founded
  • GNPX 2009
  • CVR 1920
  • Country
  • GNPX United States
  • CVR United States
  • Employees
  • GNPX N/A
  • CVR N/A
  • Industry
  • GNPX Biotechnology: Pharmaceutical Preparations
  • CVR Industrial Machinery/Components
  • Sector
  • GNPX Health Care
  • CVR Industrials
  • Exchange
  • GNPX Nasdaq
  • CVR Nasdaq
  • Market Cap
  • GNPX 10.8M
  • CVR 9.5M
  • IPO Year
  • GNPX 2018
  • CVR N/A
  • Fundamental
  • Price
  • GNPX $5.85
  • CVR $9.00
  • Analyst Decision
  • GNPX
  • CVR
  • Analyst Count
  • GNPX 0
  • CVR 0
  • Target Price
  • GNPX N/A
  • CVR N/A
  • AVG Volume (30 Days)
  • GNPX 1.8M
  • CVR 2.4K
  • Earning Date
  • GNPX 11-14-2025
  • CVR 11-11-2025
  • Dividend Yield
  • GNPX N/A
  • CVR 1.33%
  • EPS Growth
  • GNPX N/A
  • CVR N/A
  • EPS
  • GNPX N/A
  • CVR N/A
  • Revenue
  • GNPX N/A
  • CVR $25,617,681.00
  • Revenue This Year
  • GNPX N/A
  • CVR N/A
  • Revenue Next Year
  • GNPX N/A
  • CVR N/A
  • P/E Ratio
  • GNPX N/A
  • CVR N/A
  • Revenue Growth
  • GNPX N/A
  • CVR N/A
  • 52 Week Low
  • GNPX $4.60
  • CVR $8.15
  • 52 Week High
  • GNPX $117.50
  • CVR $22.27
  • Technical
  • Relative Strength Index (RSI)
  • GNPX 57.62
  • CVR 35.19
  • Support Level
  • GNPX $7.71
  • CVR $9.00
  • Resistance Level
  • GNPX $9.89
  • CVR $9.75
  • Average True Range (ATR)
  • GNPX 1.35
  • CVR 0.21
  • MACD
  • GNPX -0.24
  • CVR -0.03
  • Stochastic Oscillator
  • GNPX 43.95
  • CVR 0.25

About GNPX Genprex Inc.

Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex's oncology program utilizes its systemic, non-viral Oncoprex Delivery System which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company's product candidate, Reqorsa Immunogene Therapy (quaratusugene ozeplasmid), is being evaluated in three clinical trials as a treatment for NSCLC and SCLC.

About CVR Chicago Rivet & Machine Co.

Chicago Rivet & Machine Co is in the fastener industry in North America. The company operates in two segments namely fasteners and assembly equipment. Its fastener segment consists of the manufacture and sale of rivets, cold-formed fasteners, parts, and screw machine products. The assembly equipment segment consists mainly of the manufacture of automatic rivet setting machines, automatic assembly equipment, and parts and tools for such machines. The majority of revenue is from the fastener segment.

Share on Social Networks: